A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 (rHuPH20) Administered Intravenously in Healthy Volunteers

Publication date: Available online 19 August 2020Source: Current Therapeutic ResearchAuthor(s): Marie A. Printz, Samuel S. Dychter, Emanuel P. DeNoia, Rena Harrigan, Barry J. Sugarman, Monica Zepeda, Jennifer Souratha, David W. Kang, Daniel C. Maneval
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research